Notably, we observed highly accumulated EGFR mutations in our patients (31.5%), and the EGFR mutation rate was significantly higher in our AD patients (52.0%) than in the patients from TCGA project (13.6%) (Fisher’s exact test P = 6.69 × 10−14, Fig. 1c). Here, EGFR is linked to Alzheimer disease.